July 2026
Added to Dediabetes Jul 12, 2026RCTs
This study compared high-dose and standard-dose influenza vaccines in older adults with diabetes, finding that HD-IIV reduced hospitalizations for various diseases.
Interventions
High-dose inactivated influenza vaccine (HD-IIV)Standard-dose inactivated influenza vaccine (SD-IIV)
Outcomes
Hospitalization for any cardiorespiratory diseaseHospitalization for any cardiovascular diseaseHospitalization for influenza
Added to Dediabetes Jul 12, 2026Non Randomized CT
This case report examined the effects of high-dose vitamin D therapy on partial clinical remission in a participant with Type 1 Diabetes.
Interventions
Vitamin D supplementation
Outcomes
HbA1cInsulin-dose adjusted A1c (IDAA1c)Serum 25-hydroxyvitamin D+2 more
Added to Dediabetes Jul 12, 2026RCTs
This study evaluated the impact of high-dose Vitamin D3 supplementation on insulin resistance and glycaemic parameters in adult males with type 2 diabetes, finding no significant differences in most outcomes.
Interventions
Vitamin D supplementation
Outcomes
BMIFasting Plasma Glucose (FPG)Fasting insulin levels+4 more
Added to Dediabetes Jul 12, 2026RCTs
The AWARD-11 trial compared the effects of Dulaglutide 3.0 mg and 4.5 mg to 1.5 mg on body weight in patients with type 2 diabetes, finding significant weight reductions.
Interventions
DulaglutideDulaglutiden dose
Outcomes
Activities of daily livingBMIHbA1c+1 more
Added to Dediabetes Jul 12, 2026RCTs
This study evaluated the effects of higher doses of semaglutide on glucose levels in type 2 diabetes patients, finding modest additional benefits at higher doses.
Outcomes
Adverse events incidenceBody weightC-reactive protein+6 more
Added to Dediabetes Jul 12, 2026RCTs
This study evaluated the efficacy and safety of HRS-7535 in adults with type 2 diabetes inadequately controlled with metformin, showing significant reductions in HbA1c and fasting plasma glucose levels.
Interventions
HRS-7535 (15 mg)HRS-7535 (30 mg)HRS-7535 (60 mg)+1 more
Outcomes
Fasting Plasma Glucose (FPG)HbA1c
Added to Dediabetes Jul 12, 2026RCTs
This study examined the impact of hybrid closed-loop insulin therapy on insulin delivery patterns in youth with type 1 diabetes, finding a significant decrease in bolus insulin use.
Interventions
Insulin therapy
Outcomes
Glucose iAUC (OGTT)Insulin delivered per 10 g of carbohydrateMean daily carbohydrate-related bolus insulin+3 more
Added to Dediabetes Jul 12, 2026RCTs
This study compared diabetes-specific psychological outcomes in adults with type 1 diabetes using hybrid closed-loop therapy versus standard therapy, finding that the hybrid approach led to improved well-being and reduced distress.
Interventions
Hybrid closed-loop systemInsulin pump or multiple daily injections
Outcomes
Diabetes distress scoresFear of hypoglycemia (worry)Hypoglycemia symptom score+6 more
Added to Dediabetes Jul 12, 2026RCTs
This study evaluated a hybrid telemedicine approach for adults with type 1 diabetes against standard clinical practice, finding a significant reduction in HbA1c levels.
Interventions
Hybrid closed-loop system
Outcomes
Adverse events incidenceGlucose variabilityHbA1c+2 more
Added to Dediabetes Jul 12, 2026RCTs
This study evaluated the True Vie I3 Continuous Glucose Monitoring System in adults with diabetes, finding high agreement rates and minimal pain during sensor use.
Interventions
Continuous glucose monitoring
Outcomes
Agreement Rates for Arm SensorsAgreement rates for abdomen sensorsMean Absolute Relative Difference (MARD) for Abdomen Sensors+5 more
